1.

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

1.

Response: Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

1.

Response Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

1.

The management of cervical intra-epithelial neoplasia (CIN): Extensiveness and costs in The Netherlands

1.

Low risk of cervical cancer during a long period after negative screening in the Netherlands

2.

Low risk of cervical cancer during a long period after negative screening in the Netherlands

3.

Low risk of cervical cancer during a long period after negative screening in the Netherlands

1.

Response Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

1.

Cervical cancer screening in the United States and the Netherlands: A tale of two countries

1.

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening

1.

The nonhospital costs of care of patients with CF in The Netherlands: Results of a questionnaire